← Back to Search

Dietary Supplement

Synaquell for Healthy Subjects

N/A
Waitlist Available
Led By Michael J Stuart, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, postseason (approximately 6 months)

Summary

This trial tests the dietary supplement Synaquell on ice hockey players to see if it improves brain function. Players will take Synaquell regularly for several months, with cognitive tests conducted at different points to measure changes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, postseason (approximately 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, postseason (approximately 6 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Weight Changes
Change in brain vital signs
Secondary study objectives
Change in King-Devick Test (KDT) scores

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Synaquell GroupExperimental Treatment1 Intervention
Subjects will receive the dietary supplement, Synaquell, twice-daily during the hockey season.
Group II: Placebo GroupPlacebo Group1 Intervention
Subjects will receive the placebo twice-daily, during the hockey season.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Synaquell
2021
N/A
~140

Find a Location

Who is running the clinical trial?

Thorne Research Inc.Industry Sponsor
10 Previous Clinical Trials
400 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,316 Previous Clinical Trials
2,954,417 Total Patients Enrolled
HealthTech Connex Inc.Industry Sponsor
4 Previous Clinical Trials
124 Total Patients Enrolled
~13 spots leftby Oct 2025